Background/Aim: Long-term acid suppressants are known to have adverse effects. Its effect on gastric mucosa is not known. A cross-sectional study was undertaken to study the effect of Helicobacter pylori on gastric mucosa among patients on longterm acid suppressants.
INTRODUCTION
Dyspepsia is a common clinical entity, seen often in dayto-day practice. 1 Among them peptic ulcer disease (PUD) is the most common followed by gastroesophageal reflux disease (GERD). 2, 3 Acid suppression therapy, both proton pump inhibitors (PPI) and histamine-2 receptor antagonists (H 2 RA), are recommended empirical treatment for these patients for symptom relief and often for prolonged periods. 4 The safety of these drugs are well established. Though regarded safe, a few studies have looked into the long-term effects of these drugs on the gastric mucosa. [5] [6] [7] It is a well established fact, that prolonged acid suppression with PPI leads to hypergastrinemia, resulting in gastric mucosal hypertrophy. 8 Carcinoid tumors have been described in rodents after prolonged treatment with PPI, though not described in man. 9, 10 Though theoretically, the long-term usage of PPIs are associated with gastric mucosal changes in man, current data do not support a progression from hyperplasia to dysplastic argyrophil cell lesions in the absence of additional genetic factors. On the contrary, H 2 RA is a less potent acid suppressant; its safety is also not well established. [11] [12] [13] The main factor responsible for progression of chronic gastritis to metaplasia and dysplasia is Helicobacter pylori. The bacteria also has an influence on endocrine cell population. 14 The aim of the present study was to determine the effects of H. pylori on gastric mucosa in patients on long-term acid suppression.
Patients and Methods
This was a cross-sectional study conducted at the Department of Gastroenterology, at Stanley Medical College, Chennai, a tertiary referral center in South India. The institution caters to a large population belonging to the lower socioeconomic strata whose average per capita income is approximately Rs 1,000/-. A subspeciality dyspepsia clinic was introduced in 2005, to cater to the needs of patients with dyspepsia symptoms requiring long-term treatment for symptom relief. One hundred and twenty-six patients attending the clinic with symptoms of ulcer type (defined as an epigastric burning sensation or food related pain) or reflux type dyspepsia (heartburn and or regurgitation), for at least a year, age range between 15 and 60 years, belonging to either sex and with a normal upper endoscopy were included for the study. Sixty-six patients were on omeprazole at a dose of 20 mg a day (group I) and the rest were on ranitidine 150 mg twice a day (group II). Based on the duration of therapy, the patients in each group were further subclassified into those taking treatment for less than 2 years, 2 to 5 years and more than 5 years. A detailed demographic profile in each group included age, gender distribution, literacy level, occupational details and per capita income.
Patients in both groups had an upper endoscopy and biopsy from the fundus, body and antrum for rapid urease test, histology and for demonstration of H. pylori using hematoxylin and eosin and modified Giemsa stain. The histological changes in the gastric mucosa were interpreted by the pathologist, who was blinded to the drug details.
The demographic characteristics, details of histopathology were analyzed for statistical significance. Patients with other forms of dyspepsia like dysmotility type or those with combination types were excluded. Those with ulcer type and alarm symptoms, active smokers, recent alcoholics and NSAID abusers and those on antibiotics a fortnight prior to endoscopy were also excluded. Ethics committee of the institution approved the study.
RESULTS
The demography including age, gender distribution, literacy levels, occupation and per capita income were comparable between the two groups (p > 0.05) ( Table 1 ). The duration of treatment in the three subgroups was also similar (p > 0.05) ( Table 2) .
Gastric mucosa was normal in 18 (27.3%) and 30 (60%) patients in groups I and II respectively, which was statistically significant (p = 0.01). Ten patients (15.2%) in group I and none in group II had intestinal metaplasia (p = 0.05) ( Table 3 ). The histological findings when correlated with the duration of treatment did not reveal any significant difference between the two groups except for intestinal metaplasia which showed an increasing trend with prolonged use of proton pump inhibitors (Table 4) .
H. pylori colonized predominantly in the fundus in group I and in the antrum in group II. The colonization of H. pylori correlated with the duration of therapy in each of the two groups (Table 5 ). However, these findings were statistically not significant (p > 0.05).
When the histological changes were compared between H. pylori infected and non-H. pylori infected group, it was 
DISCUSSION
The present study has demonstrated histological changes in the gastric mucosa in a cohort of patients on long-term acid suppressants. Studies in the past, in animal models have in rat models carcinoid tumors of enterochromaffin cells, a situation akin to Zollinger-Ellison syndrome. Hypergastrinemia per se is known to act as a promoter in hyperplasia-dysplasia and neoplasia sequence.
14 Based on these observations there is a concern that longterm acid suppressants may predispose to gastric malignancy. In an earlier study, long-term PPI up to 10 years was considered safe. In fact, there has been a general amelioration of antral gastritis and gland atrophy in oxyntic mucosa in patients with reflux disease, without significant changes on atrophy or intestinal metaplasia. However, a worsening of histological changes have been reported in presence of H. pylori infection. In the present study, gastric mucosal changes were evident with both H 2 RA and PPI. With long-term H 2 RA, the gastric mucosa was frequently normal or showed mild inflammatory response. H. pylori colonization was confined to the antrum with no significant migration. However, in patients on omeprazole the gastric mucosa showed gastric atrophy and intestinal metaplasia. Also H. pylori colonization showed a migration from the antrum to the fundus with increasing duration of therapy.
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A question arises whether there is a need for an empirical eradication of H. pylori prior to recommending long-term acid suppressants especially PPIs to prevent precancerous gastric lesions, such as intestinal metaplasia. Based on our observations, H 2 RA as an antisecretory drug appears to be a better option for long-term symptom relief in patients with dyspepsia. Tachyphylaxis, though reported is often not a problem in day to day practice.
Finally, in future, whether long-term use of PPI for dyspepsia is totally safe or not needs to be addressed in larger series, especially in the absence of H. pylori infection. The present study has limitations in that this is a crosssectional study in a group of patients attending the dyspepsia clinic, whose H. pylori status at the initiation of the study was not available.
